Suite101

New Drug Brings Hope for Alzheimer's Disease Patients


© Adelle Vancil Tilton

Mar 30, 2001


Former President Ronald Reagan is one of the estimated four million Americans who have been diagnosed with Alzheimer's Disease. For years, many drugs have been available to Alzheimer's patients offering them short-term treatments, but now a new liquid drug may bring more hope to those suffering from the disease. According to researchers, an experimental drug called Neotrofin may be the world's first Alzheimer's disease therapy drug that regenerates nerve cells in the brain, potentially bringing patients long-term effects.

To date, Neotrofin has been safely tested on 1,500 people and has had positive results. Two recent studies support the belief that Neotrofin may indeed be helping Alzheimer's patients. Brain scans from patients who participated in a recent clinical study demonstrate that Neotrofin promotes brain activity in patients, leading to significant improvements in memory and judgement. In addition, at a recent medical conference in London, it was announced that Neotrofin significantly increased the number of stem cells in the brains of adult mice.

NeoTherapeutics, Inc., the California based drug company that is developing Neotrofin, is launching a new clinical trial for Alzheimer's disease this April. The new study will be held in many major metropolitan areas around the country.

For more information on participating in the clinical trials of Neotrofin please contact, 949-788-6700 ext. 300 or visit the Neotrofin website.

Go To Page: 1


The copyright of the article New Drug Brings Hope for Alzheimer's Disease Patients in Public Health Issues is owned by Adelle Vancil Tilton. Permission to republish New Drug Brings Hope for Alzheimer's Disease Patients in print or online must be granted by the author in writing.

Post this Article to facebook Add this Article to del.icio.us! Digg this Article furl this Article Add this Article to Reddit Add this Article to Technorati Add this Article to Newsvine Add this Article to Windows Live Add this Article to Yahoo Add this Article to StumbleUpon Add this Article to BlinkLists Add this Article to Spurl Add this Article to Google Add this Article to Ask Add this Article to Squidoo

Here's the follow-up discussion on this article: View all related messages
2.   May 19, 2001 3:29 AM
I kind of doubt it would cross over except possibly to Organic Brain Syndrome. I know they are working on different meds to improve memory problems associated with other medical problems, but this wh ...

-- posted by EspressoMoment
1.   Apr 8, 2001 9:13 AM
Hi Adelle,
This is great news. I wonder, would this drug be helpful for other brain disorders that involve memory loss? Very interesting and informative article, as always -- thanks!
Tina ...

-- posted by Tina_Coruth



For a complete listing of article comments, questions, and other discussions related to Adelle Vancil Tilton's Public Health Issues topic, please visit the Discussions page.


about us • limelight blog • writing jobs • careers • press room • site map • terms & conditions • privacy policy • suite101.de